Senate Panel to Probe 340B Drug Program
The Senate health committee will hold a hearing today on a drug discount program that has drawn scrutiny over whether it benefits low-income and uninsured patients.
The 340B Drug Pricing Program requires drugmakers to provide discounts for facilities that serve low-income and uninsured communities. The Senate Health, Education, Labor and Pensions Committee’s hearing comes as the safety-net initiative has ballooned in recent years, making it the second largest federal drug program in the US.
The Congressional Budget Office, which is set to testify before the committee, published a report in September that attributed ...